Hinge leverages artificial intelligence to automate education and care for joint and muscle health. Hinge has been on a high growth trajectory over the last several years as the demand for orthopedic ...

Barclays lowered the firm’s price target on Hinge Health (HNGE) to $60 from $65 and keeps an Overweight rating on the shares. The firm adjusted ...

Hinge Health priced its IPO at $32 per share on Wednesday, at the top end of the expected range. Stream NBC 5 for free, 24/7, wherever you are. The digital physical therapy startup sold 8.52 million ...

Hinge Health (NYSE:HNGE) is one of the most promising mid-cap healthcare stocks under $50. On December 19, the consensus ratings indicate a strong bullish stance towards Hinge Health (NYSE:HNGE). All ...

Digital musculoskeletal care company Hinge Health launched a women's pelvic health program, nearly two months after competitor SWORD Health revealed a similar offering. Hinge's program, available ...

The digital health IPO market hasn’t exactly been active in recent years. There was a surge in 2021, when 21 of the 57 active public digital health companies today made their debut on the public ...

Employee and government benefits organization Sun Life announced it is partnering with Hinge Health to provide its members with digital access to technology and clinicians for musculoskeletal care.

Wondering if Hinge Health is actually worth its current price, or if the market is getting ahead of itself? Let us unpack what the numbers really say about its value. The stock has been on a solid run ...

Collaboration Will Promote Best-in-Class Menopause Care for Employers and Members SAN FRANCISCO--(BUSINESS WIRE)--Hinge Health and Midi Health announced a partnership today to address the significant ...

Hinge Health priced its IPO at $32 per share on Wednesday, at the top end of the expected range. The digital physical therapy startup sold 8.52 million shares in the offering, raising about $273 ...